PMID: 44869Jan 1, 1979

The research of new antidepressants: present orientations (author's transl)

L'Encéphale
R R Fieve

Abstract

A number of promising antidepressant compounds are presently either being developed in the laboratory or are being tested clinically by pharmaceutical firms and universities around the world. New compounds are sought which will provide: 1. fewer side effects, particularly anticholinergic and cardiovascular effects; 2. more rapid onset of action than 7-10 days required of most antidepressants now used; 3. efficacy in a higher percentage of patients than the 65-70 per cent estimated to respond to currently available antidepressant therapies. Compounds now being investigated include: new tricyclics which are unlike those commonly in use; the tetracyclics; the salts of naturally occurring cations such as lithium and rubidium; and various chemically unrelated new compounds. In addition, several drugs currently being tested as anorectics seem promising for future antidepressant drugs research.

Related Concepts

Thymoleptics
Tricyclic Antidepressive Agents
Manic Disorder
Depressive Symptoms
Lithium
RIMA (Reversible Inhibitor of Monoamine Oxidase A)
Dopamine Receptor
Rubidium
Sympathomimetic Effect
Neurohormones

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

The Journal of Clinical Psychiatry
K Rickels, E Schweizer
The Journal of Clinical Psychiatry
D S Janowsky, B Byerley
General Pharmacology
P GareriG De Sarro
© 2021 Meta ULC. All rights reserved